Using this stratification system, which was similar to the categorization strategy used for the albumin-neutrophil combined prognostic grade in patients with lung cancer (23), we observed a significantly worse prognosis in the high-risk group than in the low-risk group. The gene discussed is ALB; the disease is lung cancer.